Efficacy and toxicity of rechallenge with combination immune checkpoint blockade in metastatic melanoma: a case series
Authors listLavinia Spain Gerard Walls Christina Messiou Samra Turajlic Martin Gore James Larkin
The efficacy and potential toxicity of rechallenge with combination ipilimumab and nivolumab has not been described. Retreatment of patients with immune checkpoint inhibitors in the setting of prior significant toxicity lacks evidence-based guidance.
Journal Cancer Immunology, Immunotherapy
Issue number 1